MUC5AC mucins secreted by HT-29 cells in culture are oligomeric glycoproteins with similar characteristics to the MUC5AC mucins isolated from human airways sputum Biochem. J. 347, 37-44].
Summary
MUC5AC mucins secreted by HT-29 cells in culture are oligomeric glycoproteins with similar characteristics to the MUC5AC mucins isolated from human airways sputum Biochem. J. 347, 37-44].
Therefore we have used this cell line as a model system to investigate the biosynthesis of this major airways mucin. Initial experiments showed that the MUC5AC mucins isolated from the cells were liable to depolymerisation depending on the conditions employed for their solubilisation. Prevention against reduction resulted in large oligomers associated with the cells similar to those secreted into the medium. Using a combination of density gradient centrifugation and agarose gel electrophoresis coupled with probes specific for different forms of the mucin we identified five major intracellular populations of the MUC5AC polypeptide (unglycosylated monomer and dimer, GalNAc-subsituted dimer, fully glycosylated dimer and higher-order oligomers). Pulse-chase studies were performed to follow the flow of radioactivity through these various intracellular forms into the mature oligomeric mucin secreted into the medium (the entire process taking approximately 2-4h). The results show that the mucin polypeptide undergoes dimerisation and then becomes substituted with GalNAc-residues prior to glycan elaboration to produce a mature mucin dimer which then undergoes multimerisation. These data indicate that this oligomeric mucin follows a similar assembly to the vWF glycoprotein to yield long linear disulfide-linked chains.
Introduction
In vertebrates epithelia are protected on their luminal side by mucus gels synthesised and secreted by specialised cells in the surface and/or underlying submucosa. These gels act as a physical barrier as well as providing the infrastructure to support an array of protective molecules and mechanisms for sequestering chemical toxins and pathogens. Furthermore they contribute to the homeostasis and stability of the underlying epithelium. The molecular framework of mucus is provided by large, oligomeric, O-linked glycoproteins termed mucins.
These macromolecules are polydisperse in mass (2-40 MDa) and size (0. 5-10µm in length) and are assembled from disulfide-linkage of monomers (2-3MDa) [1] [2] [3] [4] [5] .
Entanglement of the mucin chains is considered to be a major factor for gelformation and as a consequence their size distribution is a key determinant of the physical properties of the mucus.
In humans four genes encoding oligomeric mucins have been identified; MUC5AC, MUC5B, MUC2 and MUC6 and these are found in a cluster on chromosome 11 [6] . Their expression appears to be selectively controlled in a manner favouring tissue specific expression but the functional reasons for this are unclear. Sequence similarities of Cys-rich domains in the N-and C-termini of these mucins with another oligomeric, O-linked glycoprotein von Willebrand Factor (vWF) suggested that mucins were assembled in a similar manner to vWF [7] Indeed the consensus from biosynthetic studies and interactions of expressed N-and C-terminal domain constructs on human and animal oligomeric mucins indicate they share aspects of their assembly pathways with vWF [7] . It should be stressed however that the majority of these studies shed light only on the early stages in the process and the whole pathway has not yet been elucidated for any of the oligomeric mucins. Moreover, recent data in the literature indicates that oligomeric mucins are not solely linear disulfide-linked assemblies [8] [9] [10] . For example oligomeric MUC2 is assembled from disulfide-bonds as well as another reduction-insensitive linkage and may form branched structures [11, 12] .
The polydispersity of oligomeric mucins may be due to proteolytic degradation within the mucus but it may also arise as a direct consequence of by guest on October 5, 2017 http://www.jbc.org/ Downloaded from the biosynthetic process, thus allowing cellular control over the physical properties of the mucus. While intracellular proteolytic cleavage has been observed for the MUC5B mucin its structural consequence has yet to be established [13, 14] . It is likely that in disease alterations in the biosynthetic process may yield mucins with altered macromolecular structure. For instance we have shown that the mucus from an individual in status asthmaticus was comprised of MUC5B mucins with an extreme size and unusual network morphology [15] . Since mucin chain length and organisation can have profound effects on mucus rheology it is important to establish what factors impact on these aspects of mucin structure. Thus elucidation of the biosynthetic pathway is of biological and clinical importance.
In this study we have focussed on the biosynthesis of the MUC5AC mucin which is a major component in respiratory and gastric mucus [16, 17] . Recently we demonstrated that the molecular properties of this glycoprotein secreted from a sub-clone of the human carcinoma cell line HT-29 in culture were remarkably similar to the MUC5AC mucin obtained from human respiratory secretions [18] . with PBS and further incubated at 37°C in 10x methionine media (1mM).
In the first experiment to determine the time course for MUC5AC synthesis and secretion seven 75cm 2 flask were used. At each of the time points (0, 2, 6, 12 and 24h) the media was changed and pooled from each flask, for the later time points (48 and 96h) the media was changed at 24h intervals. Therefore for the 48 and 96h time points subsequent analyses were performed on the media collected only in the previous 24h. At each time point the cells were washed twice with PBS and then subsequently solubilised in 20ml of 6M GuHCl. Both pooled media and the solubilised cells were made up to 4M GuHCl and subjected to CsCl density gradient centrifugation at a starting density of 1.4g/ml as described below. The gradients were emptied into fractions and mature MUC5AC molecules were detected with the MAN-5ACI antiserum and pooled. The mucins, after reduction by the addition of 10% (v/v) 10x URB (6M Urea/1M TrisHCl/50mM EDTA pH8.0 containing 100mM DTT) for 2h at 37°C followed by carboxmethylation by the addition of 25mM iodoacetamide, were subjected to agarose gel electrophoresis and then transferred to nitrocellulose by vacuum transfer (as described above). The relative specific activity of the reduced MUC5AC subunit band was assessed by determining the ratio of the antiserum response (MAN-5ACI) to the IP buffer (without Triton X-100) preceded elution of bound molecules using two washes of 6M guanidinium chloride (GuHCl). The supernatants of these two washes were combined and subjected to CsCl/4M GuHCl isopycnic density gradient centrifugation which was performed at a starting density of 1.4g/ml at 40000rpm in a Beckman SW55 rotor for 48h at 15°C. Tubes were unloaded from the top into 17 fractions (300µl) which were then dialysed against 6M urea prior to electrophoresis on 0.7% (w/v) agarose gels.
Electron microscopy -Electron microscopy was preformed as described previuosly [18] . In brief, mucins were isolated by density gradient centrifugation and concentrated to yield stock solutions of around 50-100µg/ml. After partial reduction (10mM DTT for 10s on ice) or mechanical fragmentation (10 times through a 21 gauge needle) mucin solutions were diluted 1:500 with 10mM 
Results
We have previously demonstrated that oligomeric MUC5AC mucins are secreted from an HT-29 cell line in the form of long linear threads containing in excess of 20 subunits which can be depolymerised by reduction to yield reduced subunits of M r 2.2x10 6 and length 570nm [18] . In that study fragmentation of these molecules by controlled reduction yielded ladders of bands which were interpreted as linear assemblies of different numbers of subunits. Similar fragmentation data is presented here ( subunits [18] , and other linear fragments two and three times as long (Fig. 1B ).
These data demonstrate, as predicted from the agarose gel banding pattern, the presence of monomers, dimers and trimers in this preparation ( The MUC5AC mucin secreted into the medium by these cells has similar characteristics to its counterpart produced by human airways in that it is a distinctively glycosylated, oligomeric, linear glycoprotein of high molecular weight (Fig. 3A ) [18] . By contrast solubilisation of the cells with 6M GuHCl at pH 8 yielded mucins which were predominantly in the form of monomers and dimers (Fig. 3A) . This is in agreement with our recent study on the MUC5AC and MUC5B mucins synthesized by normal human tracheobronchial cells in culture [13] , which suggested that mucins associated with the cells (mainly dimers) were smaller than those secreted into the medium (large oligomers). From this we initially concluded that the mucins were oligomerised during or after secretion [13] . However an alternative interpretation of the data could be that the mucins To be able to set the experimental timescale for later studies we first assessed the time taken for the synthesis and secretion of 'mature' MUC5AC mucins. We therefore performed a 30min pulse label experiment and subsequently isolated the mature mucins at different times post-labelling using isopycnic density centrifugation which we have previously shown separates the mature glycosylated mucins from partially glycosylated precursors and the mucin polypeptide [19] . A cohort of labelled mature mucins was seen in the cells after 2-6h which is slowly depleted over days ( Fig. 4A & 4B) . In contrast 35 Sradiolabelled mature mucins were released into the medium within 2-6h, but thereafter their secretion was reduced dramatically, so that only a small amount was released between 24 and 96h. These data indicate that a substantial proportion of the mature molecules were kept within the cells. The fate of this material was not determined. It may be a pool awaiting the appropriate signal for secretion or may be destined for degradation.
To investigate the steps in the biosynthetic pathway it was first necessary to separate and catalogue the different intracellular forms of the mucin. To achieve this we subjected the solubilised cells to CsCl/4M GuHCl isopycnic density gradient centrifugation. The distribution of glycoconjugates in the gradient, as monitored with the PAS-reagent, shows that the majority banded between 1.32-1.48g/ml (Fig.5A ). This is consistent with the density range of mature glycosylated mucins [18] . Furthermore, over 95% of this material had similar elution behaviour on anion-exchange chromatography (after reduction and carboxymethylation) to the mature MUC5AC mucin secreted into the medium (data not shown). Aliquots from fractions taken across the density gradient were subjected to agarose electrophoresis and subsequent Western blots were probed but not the TR-probe therefore most likely contains the partially glycosylated (GalNAc) polypeptide. However we cannot be certain that the Tn-reactivity is solely due to the MUC5AC glycoprotein.
The two major bands (reactive with the TR-probe) observed at low buoyant density (Fig. 5C ) are sensitive to reduction and became a single faster migrating band after treatment with DTT (Fig. 5C inset) , suggesting that they represent different oligomerised forms of the unglycosylated mucin polypeptide.
In a previous study on the biosynthesis of MUC2 mucins [19] we identified similar bands and rate-zonal centrifugation studies indicated that the two molecular forms had sedimentation rates consistent with monomeric and dimeric species, the faster electrophoretically migrating species (corresponding to the band labelled with the open arrowhead in Fig. 5B ) representing the monomer. Identical studies (data not shown) were performed herein on material from fractions 1-3 and the same data were obtained leading us to draw the same conclusion.
To examine the progress of the mucin polypeptide through its biosynthetic pathway the cells were pulse-labelled for 1h with Fig. 6A ) and into a number of other more slowly migrating species. The assignment of the two putative polypeptide bands is confirmed by their reactivity with the anti-TR probe (Fig 6B) .
We would anticipate on the basis of the data shown in figure 5 that at least one of by guest on October 5, 2017
http://www.jbc.org/ the other bands would be a GalNAc-substituted form of the polypeptide. This is confirmed by probing the membrane with the anti-Tn antibody which showed that the 35 S-labelled band highlighted by the filled square in figure 6A , was coincident with the Tn-reactivity (Fig. 6C) . Material corresponding to the putative GalNAcsubstituted polypeptide was subsequently isolated by CsCl density gradient centrifugation and analysed, before and after reduction, by agarose gel electrophoresis (Fig. 6D) . Its change of electrophoretic mobility upon reduction indicates that it is not monomeric. Returning to the assignment of bands on the gel presented in Fig. 6A , the remaining bands (filled star and filled circle) did not stain with the anti-Tn or -TR probes (Fig. 6B & 6C ) and therefore must be more highly glycosylated forms of the mucin. We would thus propose that the uppermost bands (filled star, From figure 5 there is a clear prediction regarding the buoyant density of each of the putative molecular species assigned in figure 6 . Therefore, cells were pulse-labelled for 2h to make sure that radioactivity was found in all the intracellular forms of the mucin. Two hours post-labelling the cells were solubilised and the various MUC5AC forms were immunoprecipitated with the MAN-5ACI antiserum. The immunoprecipitate was resolubilised in 4M GuHCl and subjected to density gradient centrifugation in 4M GuHCl/CsCl, and fractions from across the gradient were subjected to agarose gel electrophoresis (Fig. 7A) . The data show that the interpretation of the bands representing mature oligomerised MUC5AC glycoproteins (Fig. 6A , filled star) is consistent with their high buoyant density (Fig. 7A, lanes 10-13) . The putative GalNAc substituted intermediate (filled square Fig. 6A ) is, as predicted, found at lower density (Fig. 7A, lanes 4-8) and almost comigrates with a mature mucin band thus explaining the broad nature of this band in are as expected the lowest density forms (Fig. 7A, lanes 1-8) . The only band not assigned earlier in figure 6 (filled circle) is shown here, by its buoyant density and R f value, to represent a fully glycosylated dimer. A very minor band (Fig. 7A, hatched symbol) which would have comigrated with the polypeptide dimer in figure 6 can now be discerned. On the basis of its buoyant density and electrophoretic mobility this band has features consistent with it being a mature mucin monomer.
Further details of the assembly of the fully glycosylated mucin were investigated by a pulse chase experiment in which the cells were labelled for 1h
and subsequently chased for up to 8h. At selected time points the mature intracellular mucins were isolated by CsCl density gradient and subjected to agarose gel electrophoresis (Fig. 7B ). Ladders were observed at each time point.
Apart from the large oligomers (>16mer), only even numbered intermediate Radioactivity is found throughout the ladders and even at the earliest time point is found in the large oligomers and there is a flow of radioactivity from the dimer into these largest species that plateaus at 2-4h.
Discussion
Until recently the majority of evidence in the literature supported the view that oligomeric mucins are linear polymers assembled in a similar fashion to the vWF glycoprotein. This was based initially on findings from cDNA studies that demonstrated shared cysteine-motifs in N-and C-termini of mucins and vWF that in the latter have been shown to be essential for oligomerisation [7] . Subsequent biosynthetic studies employing expressed C-and N-terminal domain constructs of MUC2, MUC5AC and porcine submaxiliary mucins demonstrated, as predicted from the vWF literature, that the mucins assemble via a disulfide-mediated C-C dimerisation and then an N-N multimerisation [21, 22] . However, data from studies employing N-terminal constructs of MUC2 and PSM suggest the potential for non-linear, branched mucin assemblies [8] [9] [10] . For MUC2 mucin this may not be surprising since it has been proposed to form an 'insoluble'-mucin network that is stabilised by disulfide-bonds plus additional reduction-insensitive linkage(s) [11, 12] . A non-linear architecture has also been demonstrated for a population of the MUC5B mucins isolated from the sputum of an individual in status asthmaticus which was shown to posses a branched network morphology [15] . Thus it is possible that the oligomeric mucins do not all share the same assembly pathway and differences in the pathway(s) can yield linear or branched oligomers. Furthermore, alterations in the assembly pathway in disease may give rise to alternative mucin forms which may compromise the protective function of the mucus barrier.
The data presented here for the MUC5AC mucin in this cell line favour an assembly process very similar to that for vWF yielding linear oligomeric glycoproteins. This is supported by our previous study in which we demonstrated that the MUC5AC mucins secreted from this cell line are highly oligomerised, disulfide-mediated, linear assemblies which behave as stiff random coils in solution [18] . Based on our findings, and incorporating those of others, we propose the following model for biosynthetic pathway of the MUC5AC mucin (summarised in Fig. 8 ). The mucin polypeptide is made (within 20min), folded and dimerised in the ER (within 1h) and we infer on the basis of other studies that However the data at the zero time point (Fig. 6A) shows the presence of both the polypeptide dimer and the mature dimer and therefore it seems reasonable to interpret that the GalNAc substituted form is also a dimer.
This dimer is subsequently elaborated into a fully glycosylated mucin dimer, again, with little evidence for the presence of intermediates. The next stage of the process (i.e. multimerisation) resulted in a 'ladder' of evenly-numbered oligomeric forms indicating an assembly of fully glycosylated dimers. In the longer pulse chase experiment we detect radioactivity in the largest (>16 subunits) and smallest (dimers) oligomeric species at the same early time points which
indicates that the addition of dimers can be made to already assembled multimers. This is the first report that has identified these particular molecular intermediates since many of the previous studies have employed SDS-PAGE analysis and these species would be excluded from their gels. We assume based on other evidence in the literature that the dimer-based multimerisation is mediated by disulfide bonds between N-termini [7, 8] . Thus our data further confirms that MUC5AC is assembled in a similar fashion to vWF and demonstrates molecular intermediates not identified in previous studies. Finally, our data indicates that some mature monomeric mucin is also synthesised and this may be important for chain termination as has been suggested previously by
Hansson and colleagues [25] .
We have shown that the conditions under which the cells are lysed can greatly affect the degree of oligomerisation of the MUC5AC mucins and in particular protection against reduction is critical. This supports the idea that oligomerisation is disulphide mediated, and offers an alternative explanation for our previous finding that the MUC5AC and MUC5B mucins (isolated without NEM in the lysis buffer) from NHTBE cells in air-liquid interface culture were considerably smaller than those secreted [13] . Thus the data presented here demonstrate that this is probably an artefact of cell lysis and the mucins were probably more highly oligomerised inside the cells. In support of this, we have since found that isolation of mucins from NHTBE cells employing cell lysis buffer containing NEM resulted in highly oligomersied MUC5AC and MUC5B
[unpublished observation]. Therefore it is likely that MUC5AC and MUC5B mucins synthesised in the airways are highly oligomeric macromolecules.
However, when respiratory mucins are isolated from sputum they are very polydisperse in size and mass [26] and as we show here, by agarose gel electrophoresis, the MUC5AC mucins present in airways secretions can be large The mobility of each band relative to the reduced monomer (R f ) was determined and a log 10 molecular mass versus R f plot was constructed. The M r (2.2MDa) of the reduced mucin monomer was determined previously [18] . (B) Electron microscopy was performed on the partially reduced mucin preparation and showed the presence of linear molecules with lengths consistent with monomers (approx. 500nm), dimers (approx. 1000nm) and trimers (approx. 1500nm). HT-29 cell lysates were subjected to 4M GuHCl/CsCl density gradient centrifugation and the density distribution was between 1.2 and 1.6 g/ml. (A) The glycoconjugate distribution was determined with the PAS-reagent (filled circles) [29] . Aliquots from each fraction were subjected to 0.7% (w/v) agarose gel electrophoresis. After electrophoresis the gel was treated with a reducing agent Immunoprecipitates were subjected to agarose gel electrophoresis and after electrophoresis the gel was treated with a reducing agent (10mM DTT) to reduce the mucins which were then transferred to nitrocellulose by vacuum blotting prior to (A) detection of incorporated radioactivity by phosphoimaging. The following model is based on findings presented here and those previously presented by other workers. In the ER the mucin polypeptide forms disulfide-linked dimers via their C-termini (filled circles) [7, 23, 24] . GalNAcsubstitution (late ER/golgi) then precedes glycan elaboration to yield fully glycosylated mucin dimers which multimerise via disulfide linkage between their N-termini (open circles) [7, 8] . The cellular compartments where these later steps occur are not yet known. 
